Aplikasi Platelet Rich Fibrin dan Gel Rosuvastatin 1.2% sebagai Perawatan Adjuvan pasca Open Flap Debridement pada Periodontitis Stage III Grade B pada pasien dengan kondisi premenopause

Nur Rahman Ahmad Seno Aji; Tissa Rahadianti; Dahlia Herawati

doi:10.22146/mkgk.77575

Aplikasi Platelet Rich Fibrin dan Gel Rosuvastatin 1.2% sebagai Perawatan Adjuvan pasca Open Flap Debridement pada Periodontitis Stage III Grade B pada pasien dengan kondisi premenopause

https://doi.org/10.22146/mkgk.77575

Nur Rahman Ahmad Seno Aji^(1*), Tissa Rahadianti⁽²⁾, Dahlia Herawati⁽³⁾

(1) Departemen Periodonsia, Fakultas Kedokteran Gigi, Universitas Gadjah Mada, Yogyakarta
(2) Prodi Spesialis Periodonsia, Fakultas Kedokteran Gigi, Universitas Gadjah Mada, Yogyakarta
(3) Departemen Periodonsia, Fakultas Kedokteran Gigi, Universitas Gadjah Mada, Yogyakarta
(*) Corresponding Author

Abstract

Periodontitis merupakan penyakit inflamasi jaringan pendukung gigi yang menimbulkan gangguan mastikasi, permasalahan estetika serta fonasi. Gangguan-gangguan permanen akibat periodontitis telah terbukti mempengaruhi kualitas hidup secara negatif. Periodontitis terjadi karena proses dysbiosis mikroorganisme rongga mulut dan respon inang yang inadekuat yang menyebabkan inflamasi persisten sehingga timbul destruksi jaringan periodontal. Berdasarkan tingkat keparahan dan kecepatan progresinya, periodontitis diklasifikasikan dalam stage dan grade tertentu. Periodontitis stage III Grade B merupakan kondisi penyakit periodontal tahap lanjut yang umumnya disertai poket infraboni dan kegoyangan gigi. Kondisi sistemik seperti hormon berpengaruh pada jaringan periodontal. Menjelang menopause terjadi perubahan hormon progesterone dan estrogen yang mempengaruhi integritas dan kesehatan jaringan periodontal. Modifikasi perawatan berupa penambahan bahan adjuvan pasca bedah periodontal berpengaruh positif pada periodontitis yang disertai kondisi premenopause. Platelet Rich Fibrin (PRF) merupakan salah satu olahan konsentrat platelet yang mampu menyediakan faktor pertumbuhan pada area operasi. Gel Rosuvastatin (RSV) 1,2% merupakan obat dari golongan statin yang memiliki efek pleiotrofik dan dapat berperan sebagai agen host modulation therapy (HMT) untuk mengendalikan inflamasi di jaringan periodontal. Artikel ini menyajikan sebuah alternatif perawatan fase korektif dengan aplikasi PRF dikombinasikan dengan gel rosuvastatin pada periodontitis stage III grade B sehingga diharapkan terjadi regenerasi jaringan periodontal.

Keywords

gel rosuvastatin 1,2%; periodontitis stage III grade B; platelet rich plasma; premenopause

Full Text:

PDF

References

1. World Health Organization (WHO). WHO Facts Sheets on Oral Health; 2022.

2. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018; 89(1): S159– S172.
doi: 10.1002/JPER.18-0006.

3. Albandar JM, Susin C, Hughes FJ. Manifestations of systemic diseases and conditions that affect the periodontal attachment apparatus: Case definitions and diagnostic considerations. J Periodontol. 2018; 89(1): S183-S203. doi: 10.1002/JPER.16-0480.

4. Alves RC, Félix SA, Rodriguez-Archilla A, Oliveira P, Brito J, Dos Santos JM. Relationship between menopause and periodontal disease: a cross-sectional study in a Portuguese population. Int J Clin Exp Med. 2015; 8(7): 11412-11419.

5. Caymaz MG, Uyanik LO. Comparison of the effect of advanced platelet rich fibrin and
leukocyte- and platelet-rich fibrin on outcome after removal of impacted mandibular third
molar. A randomized split mouth study. Niger J Clin Pract. 2019; 22(4): 546-552.
doi: 10.4103/njcp.njcp_473_18.

6. Deeb MA. Role of Platelet-Rich Fibrin (PRF) and Platelet-Rich Plasma (PRP) in Oro-Facial Tissue Regeneration: A Narrative Review. Journal of Advanced Oral Research.
2020; 11(1): 5-11. doi: 10.1177/2320206819895836.

7. Kobayashi E, Fluckiger L, Kobayashi MF, Sawada K, Sculean A, Schaller B, Miron RJ.
Comparative Release of Growth Factors from PRP, PRF and Advanced-PRF. Clin Oral
Investig. 2016; 20(9): 2353-2360. doi: 10.1007/s00784-016-1719-1.

8. Kobayashi MF, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. Optimized
platelet rich fibrin with the low-speed concept: growth factor release, biocompatibility and
cellular response. J Periodontol. 2017; 88(1): 112-121. doi: 10.1902/jop.2016.160443.

9. Lei L, Yu Y, Han J, Shi D, Sun W, Zhang D, Chen L. Quantification of growth factors in
advanced platelet rich fibrin and concentrated growth factors and their clinical efficiency as
adjunctive to the GTR procedure in periodontal intrabony defects. J Periodontol. 2020; 91(4):
462-472. doi: 10.1002/JPER.19-0290.

10. Masuki H, Okudera T, Watanebe T, Suzuki M, Nishiyama K, Okudera H, Nakata K, Uematsu
K, Su CY, Kawase T. Growth factor and proinflammatory cytokine contents in platelet-rich
plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF),
and concentrated growth factors (CGF). Int J Implant Dent. 2016; 2(1): 19. doi: 10.1186/s40729-016-0052-4.

11. Masahiro T, Su CY, Hidaka K, Okudera T, Matsuo M. Effect of advanced platelet-rich
fibrin on accelerating alveolar bone formation in dogs: a histological and immunofluorescence
evaluation. Anat Sci Int. 2019; 94(3): 238-244. doi: 10.1007/s12565-019-00479-1.

12. Agrawal M, Agrawal V. Platelet Rich Fibrin and Its Applications in Dentistry- A Review
Article. National Journal of Medical and Dental Research. 2014; 2(3): 51-58.

13. Agrawal S, Chaubey KK, Chaubey Agrawal V, Madan E, Agrawal MC. Clinical efficacy
of subgingıvally delivered simvastatin gel in chronic periodontitis patients. Indian Society
of Periodontology. 2016; 20(4): 409–416. doi: 10.4103/0972-124X.194270.

14. Ausenda F, Rasperini G, Acunzo RA, Pagni G. New perspectives in the use of biomaterials for
periodontal regeneration. Materials (Basel). 2019; 12: 2197-2217. doi: 10.3390/ma12132197.

15. Borie E, Olivi DG, Orsi LA, Garlet K, Weber B, Beltran V, Fuentes R. Platelet-Rich fibrin
application in dentistry: a literature review. Int J Clin Exp Med. 2015; 8(5): 7922-7929.

16. Kirzioglu FY, Bulut MT, Dogan B, Fentoglu O, Ozmen O, Carsancak SA, Ergun AB,
Ozdem M, Orhan H. Anti-inflammatory effect of rosuvastatin decreases alveolar bone loss
in experimental periodontitis. J Oral Sci. 2017; 59(2): 247-255.
doi: 10.2334/josnusd.16-0398.

17. Rahadianti T, Herawati D, Murdiastuti K. Effect of advanced-platelet rich-fibrin combined
with rosuvastatin application after open flap debridement of infrabony pocket. Majalah
Kedokteran Gigi Indonesia. 2022; 7(2): 110-117. doi: 10.22146/majkedgiind.53419.

18. Oswal S, Ravindra S, Sinha A, Manjunath S. Antibiotics in periodontal surgeries: A
prospective randomised cross over clinical trial. J Indian Soc Periodontol. 2014; 18(5):
570-574. doi: 10.4103/0972-124X.142443.

19. Fischer RG, Lira Junior R, Retamal-Valdes B, Figueiredo LC, Malheiros Z, Stewart B,
Feres M. Periodontal disease and its impact on general health in Latin America. Section
V: Treatment of periodontitis. Braz Oral Res. 2020 Apr 9; 34(1): e026.
doi: 10.1590/1807-3107bor-2020.vol34.0026.

DOI: https://doi.org/10.22146/mkgk.77575